Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis

Purpose The efficacy and safety of nimotuzumab (NTZ) added to concurrent chemoradiotherapy (CCRT) were investigated in patients with stage III–IVa nasopharyngeal carcinoma (NPC). Methods Patients with stage III–IVa NPC treated with CCRT, with or without NTZ, were screened between January 2015 and De...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cancer research and clinical oncology 2023-06, Vol.149 (6), p.2327-2344
Hauptverfasser:	Cai, Zhuochen, Chen, Dongni, Qiu, Wenze, Liang, Chixiong, Huang, Yingying, Zhou, Jiayu, Zhan, Zejiang, Xiang, Yanqun, Guo, Xiang, Lv, Xing
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Research carcinoma Chemoradiotherapy Chemoradiotherapy - adverse effects Chemotherapy clinical trials Hematology Humans Immunotherapy Induction Chemotherapy Internal Medicine Medical prognosis Medicine Medicine & Public Health Metastases Monoclonal antibodies Nasopharyngeal carcinoma Nasopharyngeal Carcinoma - drug therapy Nasopharyngeal Neoplasms - drug therapy nomogram Nomograms Oncology Original Article – Clinical Oncology Patients prognosis Prospective Studies Radiation therapy regression analysis Retrospective Studies Survival Targeted cancer therapy therapeutics Throat cancer Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!